Literature DB >> 15665064

PPAR-alpha activation required for decreased glucose uptake and increased susceptibility to injury during ischemia.

Marcello Panagia1, Geoffrey F Gibbons, George K Radda, Kieran Clarke.   

Abstract

The transcription of key metabolic regulatory enzymes in the heart is altered in the diabetic state, yet little is known of the underlying mechanisms. The aim of this study was to investigate the role of peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in modulating cardiac insulin-sensitive glucose transporter (GLUT-4) protein levels in altered metabolic states and to determine the functional consequences by assessing cardiac ischemic tolerance. Wild-type and PPAR-alpha-null mouse hearts were isolated and perfused 6 wk after streptozotocin administration or after 14 mo on a high-fat diet or after a 24-h fast. Myocardial d-[2-(3)H]glucose uptake was measured during low-flow ischemia, and differences in GLUT-4 protein levels were quantified using Western blotting. In wild-type mice in all three metabolic states, elevated plasma free fatty acids were associated with lower total cardiac GLUT-4 protein levels and decreased glucose uptake during ischemia, resulting in poor postischemic functional recovery. Although PPAR-alpha-null mice also had elevated plasma free fatty acids, they had neither decreased cardiac GLUT-4 levels nor decreased glucose uptake during ischemia and, consequently, did not have poor recovery during reperfusion. We conclude that elevated plasma free fatty acids are associated with increased injury during ischemia due to decreased cardiac glucose uptake resulting from lower cardiac GLUT-4 protein levels, the levels of GLUT-4 being regulated, probably indirectly, through PPAR-alpha activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665064     DOI: 10.1152/ajpheart.00200.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  31 in total

Review 1.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

Review 2.  Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes.

Authors:  Jennifer G Duncan
Journal:  Pediatr Cardiol       Date:  2011-02-02       Impact factor: 1.655

Review 3.  Sub-cellular localization specific SUMOylation in the heart.

Authors:  Nhat-Tu Le; James F Martin; Keigi Fujiwara; Jun-Ichi Abe
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-24       Impact factor: 5.187

4.  Influence of dark phase restricted high fat feeding on myocardial adaptation in mice.

Authors:  Ju-Yun Tsai; Carolina Villegas-Montoya; Brandon B Boland; Zachary Blasier; Oluwaseun Egbejimi; Raquel Gonzalez; Michael Kueht; Tracy A McElfresh; Rachel A Brewer; Margaret P Chandler; Molly S Bray; Martin E Young
Journal:  J Mol Cell Cardiol       Date:  2012-09-29       Impact factor: 5.000

Review 5.  Multiplexed Optical Imaging of Energy Substrates Reveals That Left Ventricular Hypertrophy Is Associated With Brown Adipose Tissue Activation.

Authors:  Marcello Panagia; Howard H Chen; Dominique Croteau; Yin-Ching Iris Chen; Chongzhao Ran; Ivan Luptak; Lee Josephson; Wilson S Colucci; David E Sosnovik
Journal:  Circ Cardiovasc Imaging       Date:  2018-03       Impact factor: 7.792

6.  A novel high-throughput screening assay for putative antidiabetic agents through PPARalpha interactions.

Authors:  Heather A Hostetler; Lindsay R Syler; Lindy N Hall; Guan Zhu; Friedhelm Schroeder; Ann B Kier
Journal:  J Biomol Screen       Date:  2008-09-23

Review 7.  PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure.

Authors:  Neville F Mistry; Sharon Cresci
Journal:  Heart Fail Rev       Date:  2008-11-08       Impact factor: 4.214

8.  Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.

Authors:  Sharon Cresci; Philip G Jones; Carmen C Sucharov; Sharon Marsh; David E Lanfear; Adam Garsa; Michael Courtois; Carla J Weinheimer; Jun Wu; Michael A Province; Daniel P Kelly; Howard L McLeod; John A Spertus
Journal:  Pharmacogenomics       Date:  2008-10       Impact factor: 2.533

9.  Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferator-activated receptor-α.

Authors:  Shouji Matsushima; Junya Kuroda; Tetsuro Ago; Peiyong Zhai; Yoshiyuki Ikeda; Shinichi Oka; Guo-Hua Fong; Rong Tian; Junichi Sadoshima
Journal:  Circ Res       Date:  2013-03-08       Impact factor: 17.367

Review 10.  Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.

Authors:  Gregory Aubert; Rick B Vega; Daniel P Kelly
Journal:  Biochim Biophys Acta       Date:  2012-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.